<HTML>
<HEAD>
<TITLE>Table 9</TITLE>
<STYLE TYPE="text/css">
<!--
.pg{position:absolute;top:0px;left:0px;height:1056px;width:816px;}
BODY{font-size:9px;color:rgb(0,0,0);background-color:rgb(255,255,255);}
.ps0{position:absolute;top:1013px;left:116px;height:7px;width:21px;}
.ps1{position:absolute;top:150px;left:147px;height:13px;width:1162px;}
.ps2{position:absolute;top:169px;left:147px;height:13px;width:319px;}
.ps3{position:absolute;top:117px;left:144px;height:10px;width:84px;}
.ps4{position:absolute;top:212px;left:139px;height:8px;width:97px;}
.ps5{position:absolute;top:212px;left:452px;height:8px;width:135px;}
.ps6{position:absolute;top:236px;left:329px;height:8px;width:450px;}
.ps7{position:absolute;top:252px;left:139px;height:8px;width:373px;}
.ps8{position:absolute;top:252px;left:452px;height:8px;width:55px;}
.ps9{position:absolute;top:268px;left:139px;height:8px;width:112px;}
.ps10{position:absolute;top:268px;left:452px;height:8px;width:140px;}
.ps11{position:absolute;top:284px;left:139px;height:8px;width:392px;}
.ps12{position:absolute;top:284px;left:452px;height:8px;width:388px;}
.ps13{position:absolute;top:300px;left:139px;height:8px;width:186px;}
.ps14{position:absolute;top:300px;left:452px;height:8px;width:511px;}
.ps15{position:absolute;top:324px;left:313px;height:8px;width:515px;}
.ps16{position:absolute;top:340px;left:139px;height:8px;width:64px;}
.ps17{position:absolute;top:340px;left:452px;height:8px;width:159px;}
.ps18{position:absolute;top:356px;left:139px;height:8px;width:290px;}
.ps19{position:absolute;top:356px;left:452px;height:8px;width:265px;}
.ps20{position:absolute;top:372px;left:139px;height:8px;width:304px;}
.ps21{position:absolute;top:372px;left:452px;height:8px;width:29px;}
.ps22{position:absolute;top:385px;left:145px;height:8px;width:335px;}
.ps23{position:absolute;top:401px;left:139px;height:8px;width:436px;}
.ps24{position:absolute;top:401px;left:452px;height:8px;width:192px;}
.ps25{position:absolute;top:417px;left:139px;height:8px;width:226px;}
.ps26{position:absolute;top:417px;left:452px;height:8px;width:162px;}
.ps27{position:absolute;top:433px;left:139px;height:8px;width:115px;}
.ps28{position:absolute;top:433px;left:452px;height:8px;width:131px;}
.ps29{position:absolute;top:449px;left:139px;height:8px;width:141px;}
.ps30{position:absolute;top:449px;left:452px;height:8px;width:202px;}
.ps31{position:absolute;top:465px;left:139px;height:8px;width:112px;}
.ps32{position:absolute;top:465px;left:452px;height:8px;width:262px;}
.ps33{position:absolute;top:481px;left:139px;height:8px;width:149px;}
.ps34{position:absolute;top:481px;left:452px;height:8px;width:118px;}
.ps35{position:absolute;top:497px;left:139px;height:8px;width:78px;}
.ps36{position:absolute;top:497px;left:452px;height:8px;width:349px;}
.ps37{position:absolute;top:513px;left:139px;height:8px;width:186px;}
.ps38{position:absolute;top:513px;left:452px;height:8px;width:434px;}
.ps39{position:absolute;top:529px;left:139px;height:8px;width:111px;}
.ps40{position:absolute;top:529px;left:452px;height:8px;width:82px;}
.ps41{position:absolute;top:545px;left:139px;height:8px;width:226px;}
.ps42{position:absolute;top:545px;left:452px;height:8px;width:118px;}
.ps43{position:absolute;top:561px;left:139px;height:8px;width:155px;}
.ps44{position:absolute;top:561px;left:452px;height:8px;width:131px;}
.ps45{position:absolute;top:577px;left:139px;height:8px;width:375px;}
.ps46{position:absolute;top:577px;left:452px;height:8px;width:55px;}
.ps47{position:absolute;top:591px;left:145px;height:8px;width:489px;}
.ps48{position:absolute;top:615px;left:303px;height:8px;width:552px;}
.ps49{position:absolute;top:631px;left:139px;height:8px;width:196px;}
.ps50{position:absolute;top:631px;left:452px;height:8px;width:130px;}
.ps51{position:absolute;top:647px;left:139px;height:8px;width:96px;}
.ps52{position:absolute;top:647px;left:452px;height:8px;width:421px;}
.ps53{position:absolute;top:663px;left:139px;height:8px;width:289px;}
.ps54{position:absolute;top:663px;left:452px;height:8px;width:295px;}
.ps55{position:absolute;top:679px;left:139px;height:8px;width:115px;}
.ps56{position:absolute;top:679px;left:452px;height:8px;width:399px;}
.ps57{position:absolute;top:695px;left:139px;height:8px;width:46px;}
.ps58{position:absolute;top:695px;left:452px;height:8px;width:79px;}
.ps59{position:absolute;top:711px;left:139px;height:8px;width:172px;}
.ps60{position:absolute;top:711px;left:452px;height:8px;width:288px;}
.ps61{position:absolute;top:727px;left:139px;height:8px;width:112px;}
.ps62{position:absolute;top:727px;left:452px;height:8px;width:575px;}
.ps63{position:absolute;top:740px;left:452px;height:8px;width:91px;}
.ps64{position:absolute;top:756px;left:139px;height:8px;width:108px;}
.ps65{position:absolute;top:756px;left:452px;height:8px;width:331px;}
.ps66{position:absolute;top:772px;left:139px;height:8px;width:228px;}
.ps67{position:absolute;top:772px;left:452px;height:8px;width:118px;}
.ps68{position:absolute;top:788px;left:139px;height:8px;width:91px;}
.ps69{position:absolute;top:788px;left:452px;height:8px;width:365px;}
.ps70{position:absolute;top:804px;left:139px;height:8px;width:162px;}
.ps71{position:absolute;top:804px;left:452px;height:8px;width:221px;}
.ps72{position:absolute;top:820px;left:139px;height:8px;width:179px;}
.ps73{position:absolute;top:820px;left:452px;height:8px;width:342px;}
.ps74{position:absolute;top:852px;left:139px;height:8px;width:1145px;}
.ps75{position:absolute;top:865px;left:149px;height:8px;width:1149px;}
.ps76{position:absolute;top:879px;left:149px;height:8px;width:1188px;}
.ps77{position:absolute;top:895px;left:139px;height:8px;width:482px;}
.ps78{position:absolute;top:911px;left:139px;height:8px;width:659px;}
.ps79{position:absolute;top:927px;left:139px;height:8px;width:166px;}
.ft0{font-family:sans-serif;white-space:pre;}
.ft1{font-weight:bold;font-size:13px;font-family:sans-serif;color:rgb(255,255,255);background-color:rgb(0,0,0);white-space:pre;}
.ft2{font-size:13px;font-family:sans-serif;white-space:pre;}
.ft3{font-weight:bold;font-size:9px;font-family:"Times New Roman",Times,serif;white-space:pre;}
.ft4{font-size:11px;font-family:sans-serif;white-space:pre;}
.em0{}
.em1{font-family:symbol,sans-serif;}
.em2{font-style:italic;}
.em3{}
.path2{position:absolute;top:990px;left:20px;height:0px;width:632px;border-top-style:solid;border-top-width:4px;border-top-color:rgb(0,0,0);; clip:   rect(   )}
.path3{position:absolute;top:162px;left:751px;height:828px;width:0px;border-left-style:solid;border-left-width:4px;border-left-color:rgb(0,0,0);}
.path4{position:absolute;top:162px;left:20px;height:0px;width:632px;border-top-style:solid;border-top-width:4px;border-top-color:rgb(0,0,0);; clip:  rect(   )}
.path5{position:absolute;top:140px;left:117px;height:56px;width:636px;background-color:rgb(0,0,0);}
.path6{position:absolute;top:211px;left:137px;height:733px;width:608px;background-color:rgb(255,255,255);}
.path7{position:absolute;top:845px;left:135px;height:0px;width:600px;border-top-style:solid;border-top-width:1px;border-top-color:rgb(0,0,0);}
.path8{position:absolute;top:229px;left:133px;height:0px;width:605px;border-top-style:solid;border-top-width:1px;border-top-color:rgb(0,0,0);}
-->
</STYLE>
<script language="JavaScript">
<!--
function MM_reloadPage(init) {  //reloads the window if Nav4 resized
  if (init==true) with (navigator) {if ((appName=="Netscape")&&(parseInt(appVersion)==4)) {
    document.MM_pgW=innerWidth; document.MM_pgH=innerHeight; onresize=MM_reloadPage; }}
  else if (innerWidth!=document.MM_pgW || innerHeight!=document.MM_pgH) location.reload();
}
MM_reloadPage(true);
// -->
</script>
<link rel="stylesheet" href="border.css" type="text/css">
</HEAD>

<BODY>
<SPAN CLASS="pg" style="left: 0px; width: 670px; height: 932px" id="Base"> 
<div id="Layer1" style="position:absolute; width:636px; height:789px; left: 21px; top: 90px; background-color: #000000; layer-background-color: #000000; border: 1px none #000000; z-index: 1" class="path2Copy"></div>
<div id="Layer2" style="position:absolute; width:630px; height:775px; z-index:2; background-color: #FFFFFF; layer-background-color: #FFFFFF; border: 1px none #000000; left: 24px; top: 100px"></div>
</SPAN> <SPAN CLASS="path5" style="left: 21px; width: 636px; top: 52px; z-index: 3" id="titlebox"></SPAN> 
<SPAN CLASS="path1" style="left: 18px; width: 638px; height: 733px" id="base2"></SPAN> 
<SPAN CLASS="path7" style="left: 30px; top: 737px; z-index: 3"></SPAN> <SPAN CLASS="path8" style="left: 30px; top: 141px; z-index: 3"></SPAN> 
<SPAN CLASS="ps0" style="left: 23px; top: 907px; z-index: 3" id="pagenumber"><SPAN CLASS="ft0">30</SPAN></SPAN> 
<SPAN CLASS="ps1" style="width: 603px; height: 13px; left: 37; top: 62px; z-index: 3"><SPAN CLASS="ft1">C&#160;<SPAN CLASS="em0">O</SPAN><SPAN CLASS="em0"> 
</SPAN><SPAN CLASS="em0">N</SPAN><SPAN CLASS="em0"> </SPAN><SPAN CLASS="em0">S</SPAN><SPAN CLASS="em0"> 
</SPAN><SPAN CLASS="em0">I</SPAN><SPAN CLASS="em0"> </SPAN><SPAN CLASS="em0">D</SPAN><SPAN CLASS="em0"> 
</SPAN><SPAN CLASS="em0">E</SPAN><SPAN CLASS="em0"> </SPAN><SPAN CLASS="em0">R</SPAN><SPAN CLASS="em0"> 
</SPAN><SPAN CLASS="em0">A</SPAN><SPAN CLASS="em0"> </SPAN><SPAN CLASS="em0">T</SPAN><SPAN CLASS="em0"> 
</SPAN><SPAN CLASS="em0">I</SPAN><SPAN CLASS="em0"> </SPAN><SPAN CLASS="em0">O</SPAN><SPAN CLASS="em0"> 
</SPAN><SPAN CLASS="em0">N</SPAN><SPAN CLASS="em0"> </SPAN><SPAN CLASS="em0">S</SPAN><SPAN CLASS="em0"> 
</SPAN>&#160;&#160;<SPAN CLASS="em0">F</SPAN><SPAN CLASS="em0"> </SPAN><SPAN CLASS="em0">O</SPAN><SPAN CLASS="em0"> 
</SPAN><SPAN CLASS="em0">R</SPAN>&#160;&#160;&#160;I&#160;<SPAN CLASS="em0">N</SPAN><SPAN CLASS="em0"> 
</SPAN><SPAN CLASS="em0">D</SPAN><SPAN CLASS="em0"> </SPAN><SPAN CLASS="em0">I</SPAN><SPAN CLASS="em0"> 
</SPAN><SPAN CLASS="em0">V</SPAN><SPAN CLASS="em0"> </SPAN><SPAN CLASS="em0">I</SPAN><SPAN CLASS="em0"> 
</SPAN><SPAN CLASS="em0">D</SPAN><SPAN CLASS="em0"> </SPAN><SPAN CLASS="em0">U</SPAN><SPAN CLASS="em0"> 
</SPAN><SPAN CLASS="em0">A</SPAN><SPAN CLASS="em0"> </SPAN><SPAN CLASS="em0">L</SPAN><SPAN CLASS="em0"> 
</SPAN><SPAN CLASS="em0">I</SPAN><SPAN CLASS="em0"> </SPAN><SPAN CLASS="em0">Z</SPAN><SPAN CLASS="em0"> 
</SPAN><SPAN CLASS="em0">I</SPAN><SPAN CLASS="em0"> </SPAN><SPAN CLASS="em0">N</SPAN><SPAN CLASS="em0"> 
</SPAN><SPAN CLASS="em0">G</SPAN>&#160;&#160;&#160;A&#160;<SPAN CLASS="em0">N</SPAN><SPAN CLASS="em0"> 
</SPAN><SPAN CLASS="em0">T</SPAN><SPAN CLASS="em0"> </SPAN><SPAN CLASS="em0">I</SPAN><SPAN CLASS="em0"> 
</SPAN><SPAN CLASS="em0">H</SPAN><SPAN CLASS="em0"> </SPAN><SPAN CLASS="em0">Y</SPAN><SPAN CLASS="em0"> 
</SPAN><SPAN CLASS="em0">P</SPAN><SPAN CLASS="em0"> </SPAN><SPAN CLASS="em0">E</SPAN><SPAN CLASS="em0"> 
</SPAN><SPAN CLASS="em0">R</SPAN><SPAN CLASS="em0"> </SPAN><SPAN CLASS="em0">T</SPAN><SPAN CLASS="em0"> 
</SPAN><SPAN CLASS="em0">E</SPAN><SPAN CLASS="em0"> </SPAN><SPAN CLASS="em0">N</SPAN><SPAN CLASS="em0"> 
</SPAN><SPAN CLASS="em0">S</SPAN><SPAN CLASS="em0"> </SPAN><SPAN CLASS="em0">I</SPAN><SPAN CLASS="em0"> 
</SPAN><SPAN CLASS="em0">V</SPAN><SPAN CLASS="em0"> </SPAN><SPAN CLASS="em0">E</SPAN></SPAN></SPAN> 
<SPAN CLASS="ps2" style="left: 37px; top: 81px; z-index: 3"><SPAN CLASS="ft1">D&#160;<SPAN CLASS="em0">R</SPAN><SPAN CLASS="em0"> 
</SPAN><SPAN CLASS="em0">U</SPAN><SPAN CLASS="em0"> </SPAN><SPAN CLASS="em0">G</SPAN>&#160;&#160;&#160;T&#160;<SPAN CLASS="em0">H</SPAN><SPAN CLASS="em0"> 
</SPAN><SPAN CLASS="em0">E</SPAN><SPAN CLASS="em0"> </SPAN><SPAN CLASS="em0">R</SPAN><SPAN CLASS="em0"> 
</SPAN><SPAN CLASS="em0">A</SPAN><SPAN CLASS="em0"> </SPAN><SPAN CLASS="em0">P</SPAN><SPAN CLASS="em0"> 
</SPAN><SPAN CLASS="em0">Y</SPAN>&#160;*</SPAN></SPAN> <SPAN CLASS="ps3" style="left: 290; width: 84px; top: 29; z-index: 3" id="tablelabel"><SPAN CLASS="ft2"><b>Table 
9<a name="table9"></a></b></SPAN></SPAN> <SPAN CLASS="ps4" style="left: 34; top: 124px; z-index: 3; width: 97px"><SPAN CLASS="ft3">Indication</SPAN></SPAN> 
<SPAN CLASS="ps5" style="left: 340; top: 124px; z-index: 3"><SPAN CLASS="ft3">Drug 
Therapy</SPAN></SPAN> <SPAN CLASS="ps6" style="width: 416px; height: 8px; left: 218px; top: 148px; z-index: 3"><SPAN CLASS="ft3">Compelling 
Indications Unless Contraindicated</SPAN></SPAN> <SPAN CLASS="ps7" style="left: 34px; top: 164px; z-index: 3; width: 250"><SPAN CLASS="ft0">Diabetes 
mellitus (type 1) with proteinuria</SPAN></SPAN> <SPAN CLASS="ps8" style="left: 337px; top: 164px; z-index: 3"><SPAN CLASS="ft4">ACE 
I</SPAN></SPAN> <SPAN CLASS="ps9" style="left: 34px; top: 180px; z-index: 3"><SPAN CLASS="ft0">Heart 
failure</SPAN></SPAN> <SPAN CLASS="ps10" style="left: 337px; top: 180px; z-index: 3"><SPAN CLASS="ft0">ACE 
I, diuretics</SPAN></SPAN> <SPAN CLASS="ps11" style="left: 34px; top: 196px; z-index: 3; width: 250px"><SPAN CLASS="ft0"><font color="#FF0000">Isolated 
systolic hypertension (older patients)</font></SPAN></SPAN> <SPAN CLASS="ps12" style="width: 292px; height: 8px; left: 337px; top: 196px; z-index: 3"><SPAN CLASS="ft0"><font color="#FF0000">Diuretics 
(preferred), CA (long-acting DHP)</font></SPAN></SPAN> <SPAN CLASS="ps13" style="left: 34px; top: 212px; z-index: 3"><SPAN CLASS="ft0">Myocardial 
infarction</SPAN></SPAN> <SPAN CLASS="ps14" style="width: 292px; height: 8px; left: 337px; top: 212px; z-index: 3"><SPAN CLASS="ft0">Beta-blockers 
(non-ISA), ACE I (with systolic dysfunction)</SPAN></SPAN> <SPAN CLASS="ps15" style="width: 430px; height: 8px; left: 198px; top: 236px; z-index: 3"><SPAN CLASS="ft3">May 
Have Favorable Effects on Comorbid Conditions&#134;</SPAN></SPAN> <SPAN CLASS="ps16" style="left: 34px; top: 252px; z-index: 3"><SPAN CLASS="ft0">Angina</SPAN></SPAN> 
<SPAN CLASS="ps17" style="left: 337px; top: 252px; z-index: 3"><SPAN CLASS="ft0">Beta-blockers, 
CA</SPAN></SPAN> <SPAN CLASS="ps18" style="left: 33px; top: 267px; z-index: 3"><SPAN CLASS="ft0">Atrial 
tachycardia and fibrillation</SPAN></SPAN> <SPAN CLASS="ps19" style="left: 337px; top: 267px; z-index: 3"><SPAN CLASS="ft0">Beta-blockers, 
CA (non-DHP)</SPAN></SPAN> <SPAN CLASS="ps20" style="left: 34px; top: 282; z-index: 3"><SPAN CLASS="ft0">Cyclosporine-induced 
hypertension</SPAN></SPAN> <SPAN CLASS="ps21" style="left: 337px; top: 282px; z-index: 3"><SPAN CLASS="ft0">CA</SPAN></SPAN> 
<SPAN CLASS="ps22" style="left: 38; top: 297px; z-index: 3"><SPAN CLASS="ft0">(caution 
with the dose of cyclosporine)</SPAN></SPAN> <SPAN CLASS="ps23" style="left: 34; top: 312px; z-index: 3; width: 280"><SPAN CLASS="ft0">Diabetes 
mellitus (types 1 and 2) with proteinuria</SPAN></SPAN> <SPAN CLASS="ps24" style="left: 337px; top: 312px; z-index: 3; width: 192px"><SPAN CLASS="ft0">ACE 
I (preferred), CA</SPAN></SPAN> <SPAN CLASS="ps25" style="left: 34; top: 327px; z-index: 3"><SPAN CLASS="ft0">Diabetes 
mellitus (type 2)</SPAN></SPAN> <SPAN CLASS="ps26" style="left: 337px; top: 327px; z-index: 3"><SPAN CLASS="ft0">Low-dose 
diuretics</SPAN></SPAN> <SPAN CLASS="ps27" style="left: 34; top: 342px; z-index: 3"><SPAN CLASS="ft0">Dyslipidemia</SPAN></SPAN> 
<SPAN CLASS="ps28" style="left: 337px; top: 342; z-index: 3"><SPAN CLASS="ft0">Alpha-blockers</SPAN></SPAN> 
<SPAN CLASS="ps29" style="left: 34; top: 357; z-index: 3"><SPAN CLASS="ft0">Essential 
tremor</SPAN></SPAN> <SPAN CLASS="ps30" style="left: 337px; top: 357px; z-index: 3"><SPAN CLASS="ft0">Beta-blockers 
(non-CS)</SPAN></SPAN> <SPAN CLASS="ps31" style="left: 34; top: 372px; z-index: 3"><SPAN CLASS="ft0">Heart 
failure</SPAN></SPAN> <SPAN CLASS="ps32" style="left: 337px; top: 372px; z-index: 3"><SPAN CLASS="ft0">Carvedilol, 
losartan potassium</SPAN></SPAN> <SPAN CLASS="ps33" style="left: 34; top: 387px; z-index: 3"><SPAN CLASS="ft0">Hyperthyroidism</SPAN></SPAN> 
<SPAN CLASS="ps34" style="left: 337px; top: 387px; z-index: 3"><SPAN CLASS="ft0">Beta-blockers</SPAN></SPAN> 
<SPAN CLASS="ps35" style="left: 34; top: 402px; z-index: 3"><SPAN CLASS="ft0">Migraine</SPAN></SPAN> 
<SPAN CLASS="ps36" style="width: 293px; height: 8px; left: 337px; top: 402px; z-index: 3"><SPAN CLASS="ft0">Beta-blockers 
(non-CS), CA (non-DHP)</SPAN></SPAN> <SPAN CLASS="ps37" style="left: 34; top: 417px; z-index: 3"><SPAN CLASS="ft0">Myocardial 
infarction</SPAN></SPAN> <SPAN CLASS="ps38" style="width: 293px; left: 337px; top: 417px; z-index: 3"><SPAN CLASS="ft0">Diltiazem 
hydrochloride, verapamil hydrochloride</SPAN></SPAN> <SPAN CLASS="ps39" style="left: 34; top: 432px; z-index: 3"><SPAN CLASS="ft0">Osteoporosis</SPAN></SPAN> 
<SPAN CLASS="ps40" style="left: 337px; top: 432px; z-index: 3"><SPAN CLASS="ft0">Thiazides</SPAN></SPAN> 
<SPAN CLASS="ps41" style="left: 34; top: 447px; z-index: 3"><SPAN CLASS="ft0">Preoperative 
hypertension</SPAN></SPAN> <SPAN CLASS="ps42" style="left: 337px; top: 447px; z-index: 3"><SPAN CLASS="ft0">Beta-blockers</SPAN></SPAN> 
<SPAN CLASS="ps43" style="left: 34px; top: 462px; z-index: 3"><SPAN CLASS="ft0">Prostatism 
(BPH)</SPAN></SPAN> <SPAN CLASS="ps44" style="left: 337px; top: 462px; z-index: 3"><SPAN CLASS="ft0">Alpha-blockers</SPAN></SPAN> 
<SPAN CLASS="ps45" style="left: 34px; top: 477px; z-index: 3; width: 280px"><SPAN CLASS="ft0">Renal 
insufficiency (caution in renovascular</SPAN></SPAN> <SPAN CLASS="ps46" style="left: 337px; top: 477px; z-index: 3; width: 55px"><SPAN CLASS="ft4">ACE 
I</SPAN></SPAN> <SPAN CLASS="ps47" style="left: 40px; top: 492px; z-index: 3"><SPAN CLASS="ft0">hypertension 
and creatinine &#62;265.2 <SPAN CLASS="em1">m</SPAN>mol/L [3 mg/dL])</SPAN></SPAN> 
<SPAN CLASS="ps48" style="width: 442px; height: 8px; left: 188px; top: 515px; z-index: 3"><SPAN CLASS="ft3">May 
Have Unfavorable Effects on Comorbid Conditions&#134;&#135;</SPAN></SPAN> <SPAN CLASS="ps49" style="left: 34px; top: 530px; z-index: 3"><SPAN CLASS="ft0">Bronchospastic 
disease</SPAN></SPAN> <SPAN CLASS="ps50" style="left: 337px; top: 530px; z-index: 3"><SPAN CLASS="ft0">Beta-blockers&#167;</SPAN></SPAN> 
<SPAN CLASS="ps51" style="left: 34px; top: 545px; z-index: 3"><SPAN CLASS="ft0">Depression</SPAN></SPAN> 
<SPAN CLASS="ps52" style="width: 293px; left: 337px; top: 545px; z-index: 3"><SPAN CLASS="ft0">Beta-blockers, 
central alpha-agonists, reserpine&#167;</SPAN></SPAN> <SPAN CLASS="ps53" style="left: 34px; top: 560px; z-index: 3"><SPAN CLASS="ft0">Diabetes 
mellitus (types 1 and 2)</SPAN></SPAN> <SPAN CLASS="ps54" style="left: 337px; top: 560px; z-index: 3"><SPAN CLASS="ft0">Beta-blockers, 
high-dose diuretics</SPAN></SPAN> <SPAN CLASS="ps55" style="left: 34px; top: 575px; z-index: 3"><SPAN CLASS="ft0">Dyslipidemia</SPAN></SPAN> 
<SPAN CLASS="ps56" style="width: 293px; left: 337px; top: 575px; z-index: 3"><SPAN CLASS="ft0">Beta-blockers 
(non-ISA), diuretics (high-dose)</SPAN></SPAN> <SPAN CLASS="ps57" style="left: 34px; top: 590px; z-index: 3"><SPAN CLASS="ft4">Gout</SPAN></SPAN> 
<SPAN CLASS="ps58" style="left: 337px; top: 590px; z-index: 3"><SPAN CLASS="ft0">Diuretics</SPAN></SPAN> 
<SPAN CLASS="ps59" style="left: 34px; top: 605"><SPAN CLASS="ft0">2&#176;&#160;or 
3&#176;&#160;heart block</SPAN></SPAN> <SPAN CLASS="ps60" style="left: 337px; top: 605px; z-index: 3"><SPAN CLASS="ft0">Beta-blockers,&#167; 
CA (non-DHP)&#167;</SPAN></SPAN> <SPAN CLASS="ps61" style="left: 34px; top: 620px; z-index: 3"><SPAN CLASS="ft0">Heart 
failure</SPAN></SPAN> <SPAN CLASS="ps62" style="width: 293px; left: 337px; top: 620px; z-index: 3"><SPAN CLASS="ft0">Beta-blockers 
(except carvedilol), CA (except amlodipine besylate,</SPAN></SPAN> <SPAN CLASS="ps63" style="left: 337px; top: 635px; z-index: 3"><SPAN CLASS="ft0">felodipine)</SPAN></SPAN> 
<SPAN CLASS="ps64" style="left: 34px; top: 650px; z-index: 3"><SPAN CLASS="ft0">Liver 
disease</SPAN></SPAN> <SPAN CLASS="ps65" style="width: 292px; height: 8px; left: 337px; top: 650px; z-index: 3"><SPAN CLASS="ft0">Labetalol 
hydrochloride, methyldopa&#167;</SPAN></SPAN> <SPAN CLASS="ps66" style="left: 34px; top: 665px; z-index: 3"><SPAN CLASS="ft0">Peripheral 
vascular disease</SPAN></SPAN> <SPAN CLASS="ps67" style="left: 337px; top: 665px; z-index: 3"><SPAN CLASS="ft0">Beta-blockers</SPAN></SPAN> 
<SPAN CLASS="ps68" style="left: 34px; top: 680px; z-index: 3"><SPAN CLASS="ft0">Pregnancy</SPAN></SPAN> 
<SPAN CLASS="ps69" style="width: 292px; height: 8px; left: 337px; top: 680px; z-index: 3"><SPAN CLASS="ft0">ACE 
I,&#167; angiotensin II receptor blockers&#167;</SPAN></SPAN> <SPAN CLASS="ps70" style="left: 34px; top: 695px; z-index: 3"><SPAN CLASS="ft0">Renal 
insufficiency</SPAN></SPAN> <SPAN CLASS="ps71" style="left: 337px; top: 695px; z-index: 3"><SPAN CLASS="ft0">Potassium-sparing 
agents</SPAN></SPAN> <SPAN CLASS="ps72" style="left: 34px; top: 710px; z-index: 3"><SPAN CLASS="ft0">Renovascular 
disease</SPAN></SPAN> <SPAN CLASS="ps73" style="width: 292px; height: 8px; left: 337px; top: 710px; z-index: 3"><SPAN CLASS="ft0">ACE 
I, angiotensin II receptor blockers</SPAN></SPAN> <SPAN CLASS="ps74" style="width: 604px; height: 8px; left: 34px; top: 740; z-index: 3"><SPAN CLASS="ft0">*&#160;&#160;For 
initial drug therapy recommendations, see figure 8. &#160;For references, see 
chapter 4, <SPAN CLASS="em2">Physicians&#146;</SPAN><SPAN CLASS="em2"> </SPAN><SPAN CLASS="em2">Desk</SPAN><SPAN CLASS="em2"> 
</SPAN><SPAN CLASS="em2">Reference</SPAN><SPAN CLASS="em2"> </SPAN>(51st edition), 
and</SPAN></SPAN> <SPAN CLASS="ps75" style="width: 593px; height: 8px; left: 34px; top: 754px; z-index: 3"><SPAN CLASS="ft0">Kaplan 
and Gifford.<SPAN CLASS="em3"><SUP>134</SUP></SPAN>&#160;&#160;ACE I indicates 
angiotensin-converting enzyme inhibitors; BPH, benign prostatic hyperplasia; CA, 
calcium</SPAN></SPAN> <SPAN CLASS="ps76" style="width: 594px; height: 8px; left: 34px; top: 768px; z-index: 3"><SPAN CLASS="ft0">antagonists; 
DHP, dihydropyridine; ISA, intrinsic sympathomimetic activity; MI, myocardial 
infarction; and non-CS, noncardioselective.</SPAN></SPAN> <SPAN CLASS="ps77" style="left: 34px; top: 782px; z-index: 3"><SPAN CLASS="ft0">&#134;&#160;&#160;Conditions 
and drugs are listed in alphabetical order.</SPAN></SPAN> <SPAN CLASS="ps78" style="width: 606px; height: 8px; left: 34px; top: 796px; z-index: 3"><SPAN CLASS="ft0">&#135;&#160;&#160;These 
drugs may be used with special monitoring unless contraindicated.</SPAN></SPAN> 
<SPAN CLASS="ps79" style="left: 34px; top: 810px; z-index: 3"><SPAN CLASS="ft0">&#167;&#160;&#160;Contraindicated.</SPAN></SPAN> 
</BODY>

</HTML>
